• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Verastem Inc (NQ: VSTM )

    2.819 +0.029 (+1.04%)
    Streaming Delayed Price Updated: 11:20 AM EDT, Jul 10, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Verastem Inc

    < Previous 1 2 3 4 5 6 7 8 Next >
    Verastem Oncology Outlines Key 2022 Strategic Priorities and Upcoming Catalysts for Advancing VS-6766 as a Backbone of Therapy for RAS Pathway-Driven Cancers
    From Verastem Oncology
    Via Business Wire
    Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Verastem Oncology
    Via Business Wire
    Verastem Oncology to Participate in Upcoming Investor Conferences
    From Verastem Oncology
    Via Business Wire
    Stocks That Hit 52-Week Lows On Thursday
    On Thursday, 615 stocks hit new 52-week lows. Noteable 52-Week Lows: Sea (NYSE:SE) is the largest company in terms of market cap to set a new 52-week low this... 
    Via Benzinga
    The Daily Biotech Pulse: Novartis Snags Twin FDA Nods, Novavax Positive Vaccine News Continues, Arcutis Psoriasis Application Accepted For Review
    Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Novartis Receives FDA Nods For Arthritis Treatment And Cholesterol Drug... 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Gainers iSpecimen (NASDAQ:ISPC) stock rose 31.09% to $6.45 during Monday's pre-market session. The company's market cap stands at $44.9 million. Provention Bio (... 
    Via Benzinga
    Mirati Therapeutics and Verastem Oncology Partner to Evaluate Adagrasib in Combination with VS-6766 in KRASG12C-Mutant Non-Small Cell Lung Cancer
    From Verastem Oncology
    Via Business Wire
    Verastem Oncology to Present at the Jefferies London Healthcare Conference
    From Verastem Oncology
    Via Business Wire
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Gainers Autolus Therapeutics (NASDAQ:AUTL) stock rose 21.04% to $6.73 during Monday's pre-market session. The company's market cap stands at $490.7 million. As per... 
    Via Benzinga
    Verastem Oncology Reports Third Quarter 2021 Financial Results and Highlights Recent Company Progress
    From Verastem Oncology
    Via Business Wire
    Verastem Oncology Appoints Michelle Robertson to Board of Directors
    From Verastem Oncology
    Via Business Wire
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Gainers Tenet Healthcare (NYSE:THC) stock r... 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Gainers Paratek Pharmaceuticals (NASDAQ:PRTK... 
    Via Benzinga
    Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Verastem Oncology
    Via Business Wire
    Verastem Oncology Appoints Louis J. Denis, M.D., as Chief Medical Officer
    From Verastem Oncology
    Via Business Wire
    Why Verastem Stock Spiked Today
    A clinical collaboration with biotech titan Amgen briefly lit a fire underneath Verastem's shares today. 
    Via The Motley Fool
    Why Verastem Shares Are Trading Higher Today
    Verastem Inc (NASDAQ: VSTM) is trading higher Monday after the company announced updated investigator-sponsored Phase 1/2 FRAME study data of VS-6766 with defactinib in low-... 
    Via Benzinga
    35 Stocks Moving In Monday's Mid-Day Session
    Gainers ZIVO Bioscience, Inc. (NASDAQ: ZIVO) jumped 145% to $6.86 after declining around 17% on Friday. Edesa Biotech, Inc. (NASDAQ: EDSA) jumped 30.6% to $7.68 after the company... 
    Via Benzinga
    Penny Biotech Stocks: 8 Things for Verastem Investors to Know as VSTM Stock Shoots Higher
    Verastem (VSTM) stock is on the rise Monday morning following an announcement from the company concerning a deal with Amgen (AMGN). 
    Via InvestorPlace
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Gainers Verastem (NASDAQ:VSTM) shares moved upwards by 22.1% to $3.37 during Monday's pre-market session. The company's market cap stands at $609.1 million.... 
    Via Benzinga
    24 Stocks Moving in Monday's Pre-Market Session
    Gainers Verastem, Inc. (NASDAQ: VSTM) rose 30.8% to $3.61 in pre-market trading after the company announced a mini oral presentation highlighting updated data from the ongoing... 
    Via Benzinga
    Verastem Oncology and Amgen Partner to Evaluate VS-6766 in Combination with LUMAKRASTM (Sotorasib) in Patients with KRAS G12C-Mutant Non-Small Cell Lung Cancer
    From Verastem Oncology
    Via Business Wire
    Verastem Shares Are Trading Higher On Encouraging Combo Therapy Data At ESMO Presentation
    Verastem Oncology Inc (NASDAQ: VSTM) stock is trading higher after updated data from the ongoing Phase 1/2 FRAME study. The investigator-sponsored study is... 
    Via Benzinga
    Verastem Oncology Announces Updated Investigator-Sponsored Phase 1/2 FRAME Study Data of VS-6766 with Defactinib in Low-Grade Serous Ovarian Cancer Showing Encouraging Response Rates and Progression-Free Survival Presented at ESMO 2021
    From Verastem Oncology
    Via Business Wire
    The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight
    Biotech stocks declined for the week ending Sept. 17, extending the losses from the previous week. European Society for Medical Oncology presentations, vaccine news, clinical... 
    Via Benzinga
    Exposures Product Safety
    Verastem Oncology to Present at Upcoming Investor Conferences
    From Verastem Oncology
    Via Business Wire
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Gainers Outlook Therapeutics (NASDAQ:OTLK) shares increased by 38.49% to $3.13 during Tuesday's pre-market session. The company's market cap stands at $543.3... 
    Via Benzinga
    Verastem Oncology Reports Second Quarter 2021 Financial Results and Highlights Recent Company Progress
    From Verastem Oncology
    Via Business Wire
    Verastem Oncology Announces Updated Phase 1/2 FRAME Study Data in Low Grade Serous Ovarian Cancer Selected for a Mini Oral Presentation at the European Society of Medical Oncology Congress 2021
    From Verastem Oncology
    Via Business Wire
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Gainers Dynatronics (NASDAQ:DYNT) shares moved upwards by 40.31% to $1.81 during Monday's pre-market session. The company's market cap stands at $31.4 million.... 
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.